top of page

Ongoing Clinical Trials in IgA Nephropathy

ATRASENTAN: ALIGN and AFFINITY

Atrasentan is an Endothelin A (ETA) receptor antagonist...

BION-1301

BION-1301 is a novel humanized anti-APRIL monoclonal antibody...

Narsoplimab: ARTEMIS-IgAN

Some patients with IgAN have  lectin pathway activation...

Ravulizumab: SANCTUARY

Local complement activation in the mesangium...

SPARSENTAN- SPARTAN and PROTECT

Increased production of ET 1 has been associated with...

IONIS-FB-LRx

IONIS-FB-LRx is a ligand-conjugated (LICA) investigational antisense medicine...

AT-1501 (Tegoprubart)

Tegoprubart is a next generation monoclonal antibody...

IPTACOPAN: APPLAUSE-IgAN

Local activation of the alternative complement...

List of Updated Clinical Trials for IgA

bottom of page